JP2022538170A5 - - Google Patents

Info

Publication number
JP2022538170A5
JP2022538170A5 JP2021577157A JP2021577157A JP2022538170A5 JP 2022538170 A5 JP2022538170 A5 JP 2022538170A5 JP 2021577157 A JP2021577157 A JP 2021577157A JP 2021577157 A JP2021577157 A JP 2021577157A JP 2022538170 A5 JP2022538170 A5 JP 2022538170A5
Authority
JP
Japan
Prior art keywords
treatment
lemborexant
pharmaceutically acceptable
acceptable salt
oral medication
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021577157A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022538170A (ja
Filing date
Publication date
Priority claimed from PCT/US2019/067955 external-priority patent/WO2020263331A1/en
Application filed filed Critical
Priority claimed from PCT/US2020/039674 external-priority patent/WO2020264201A1/en
Publication of JP2022538170A publication Critical patent/JP2022538170A/ja
Publication of JP2022538170A5 publication Critical patent/JP2022538170A5/ja
Priority to JP2025076606A priority Critical patent/JP2025116005A/ja
Pending legal-status Critical Current

Links

JP2021577157A 2019-06-26 2020-06-25 睡眠問題の治療のためのレンボレキサント Pending JP2022538170A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025076606A JP2025116005A (ja) 2019-06-26 2025-05-02 睡眠問題の治療のためのレンボレキサント

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
USPCT/US2019/003933 2019-06-26
US2019003933 2019-06-26
USPCT/US2019/067955 2019-12-20
PCT/US2019/067955 WO2020263331A1 (en) 2019-06-26 2019-12-20 Lemborexant for treating sleep issues
PCT/US2020/039674 WO2020264201A1 (en) 2019-06-26 2020-06-25 Lemborexant for treating sleep issues

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025076606A Division JP2025116005A (ja) 2019-06-26 2025-05-02 睡眠問題の治療のためのレンボレキサント

Publications (2)

Publication Number Publication Date
JP2022538170A JP2022538170A (ja) 2022-08-31
JP2022538170A5 true JP2022538170A5 (cg-RX-API-DMAC7.html) 2023-06-21

Family

ID=83059912

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021577157A Pending JP2022538170A (ja) 2019-06-26 2020-06-25 睡眠問題の治療のためのレンボレキサント
JP2025076606A Pending JP2025116005A (ja) 2019-06-26 2025-05-02 睡眠問題の治療のためのレンボレキサント

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025076606A Pending JP2025116005A (ja) 2019-06-26 2025-05-02 睡眠問題の治療のためのレンボレキサント

Country Status (1)

Country Link
JP (2) JP2022538170A (cg-RX-API-DMAC7.html)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6659681B2 (ja) * 2014-10-23 2020-03-04 エーザイ・アール・アンド・ディー・マネジメント株式会社 不眠症を治療するための組成物および方法
RU2763493C2 (ru) * 2016-05-12 2021-12-29 Эйсай Ар Энд Ди Менеджмент Ко., Лтд. Способы лечения расстройств циркадного ритма сна

Similar Documents

Publication Publication Date Title
TW389696B (en) Accelerated release composition containing bromocriptine
JP2022522270A5 (cg-RX-API-DMAC7.html)
JP2505944B2 (ja) (S)―α―フルオロメチル―ヒスチジン及びそのエステルを含有するぜん息治療用医薬組成物
JP2021120379A5 (cg-RX-API-DMAC7.html)
TW200412934A (en) Pharmaceutical formulations of modafinil
JP2009543761A (ja) レボドパ/カルビドパの長期間24時間腸内投与
JP2010535805A5 (cg-RX-API-DMAC7.html)
JP2009508854A (ja) 睡眠時呼吸障害の予防及び治療方法及び手段
JP2026035701A5 (cg-RX-API-DMAC7.html)
ES2865278T3 (es) Amantadina para mejorar la marcha en esclerosis múltiple
JP2022521233A5 (cg-RX-API-DMAC7.html)
CN100558358C (zh) 唑尼沙胺在制备用于治疗或预防阻塞性睡眠呼吸暂停的药物中的应用
JP2011520980A5 (cg-RX-API-DMAC7.html)
US20200030372A1 (en) Alleviating common cold and influenza symptoms with molecular hydrogen
JP2005512946A5 (cg-RX-API-DMAC7.html)
JP2004525940A (ja) 火照りの処置のためのデュロキセチン
JP2009545546A (ja) リウマチ性疾患の遅延放出型グルココルチコイド治療
Bernatoniene et al. Oral berotralstat for hereditary angioedema prophylaxis in patients aged 2 to< 12 years: APeX-P interim results
WO2017064652A2 (en) Low dose oral dipyridamole compositions and uses thereof
JP6514420B2 (ja) 睡眠時無呼吸の処置のためのスルチアム
JP2024084670A5 (cg-RX-API-DMAC7.html)
JP2021530568A5 (cg-RX-API-DMAC7.html)
CN111358803A (zh) 包含稀有人参皂苷Rg6和F4的改善睡眠药物组合物
JP4384435B2 (ja) くしゃみ抑制組成物
JP2024523876A5 (cg-RX-API-DMAC7.html)